Home Specialties - Our Doctors Dr Giannis Chatzimichail

We Provide American Medical Standards World Class Doctors State of the Art Facilities Prestigious Medical Services Cutting Edge Technologies Patient Centeredness

Dr Giannis Chatzimichail

Dermatology

Gesy registered Dermatologist - Venereologist, Dr. med. Giannis Chatzimichail started his medical journey back in 2004 at the Department of Medicine of the University of Patras, Greece. For many years, he worked as a specialist Dermatologist at the world-renowned dermatology clinic of the University of Lübeck, Germany, where he completed his residency as well as his Ph.D. in Psoriasis and Biologics. His mentors were the famous Professors of Dermatology Detlef Zillikens and Diamant Thaci. Besides classical clinical Dermatology and Venereology, his expertise includes pediatric dermatology, Dermatohistopathology, Skin Surgery, diagnostic Phlebology, Allergology, dermatological Laser, and Cosmetology.

He is fluent in English, German, and Greek.

In September 2021, he joined us at AIMIS Clinics and has ever since been a valuable asset to our team of medical specialists.

09/2021 - Present: Γεσυ registered Dermatologist -Venereologist at AIMIS Clinics

02/2021 - 04/2021: Specialist Dermatologist - Venereologist at the Dermatology Clinic of the University of Lübeck, Germany

09/2017 - 11/2020: PhD in Psoriasis at the Institute of Inflammatory Diseases University of Lübeck, Germany

09/2012 - 01/2021: Residency in Dermatology, Venereology and Allergology

08/2010 - 08/2011: Pre-registration Doctor, at the Ammochostos General Hospital Cyprus

10/2004 - 07/2010: MD, Department of Medicine at the University of Patras, Greece

Chatzimichail G, Zillikens D, Thaçi D. Secukinumab-Induced Chronic Discoid Lupus Erythematosus. JAAD Case Reports 6(4): 362–64.

Chatzimichail G, Günther J, Ständer S, Thaçi D. Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis. A 2-year, monocentric, retrospective study. ePoster presented at the 29th European Academy of Dermatology and Venereology 29-31st October, 2020 Virtual Congress.

Trense Y, Schlüter K, Chatzimichail G, et al. Influence of the IL-17A Inhibitor Secukinumab on the Expression of Anti-microbial Peptides in Lesional Skin of Psoriasis Patients. ePoster presented at the 29th European Academy of Dermatology and Venereology 29-31st October, 2020 Virtual Congress.

Chatzimichail G, Günther J, Ständer S, Thaçi D. Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis. A 2-year, monocentric, retrospective study.

(ID: 1854428 DOI:10.1080/09546634.2020.1854428). Journal of Dermatological Treatment. 14.11.2020 accepted for publication. 11.01.2021 published online.